Beijing VDJBio Co., LTD.
5 clinical trials · Sponsor
◉ Watch Beijing VDJBio Co., LTD.
| Record | Firm | Date |
|---|---|---|
| Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis (NCT06726096) | Beijing VDJBio Co., LTD. | 2025-04-09 |
| Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis (NCT05957107) | Beijing VDJBio Co., LTD. | 2022-05-26 |
| A Study of Anti-IL-6R mAb Injection in Patients With iMCD (NCT05345522) | Beijing VDJBio Co., LTD. | 2022-04-18 |
| Clinical Study of Recombinant Humanized CTLA-4-FC Fusion Protein Injection in Healthy Subjects (NCT05256719) | Beijing VDJBio Co., LTD. | 2021-09-21 |
| Clinical Study of Single Dose IL-6R mAb Injection in RA Patients (NCT05232396) | Beijing VDJBio Co., LTD. | 2021-03-02 |
Track Beijing VDJBio Co., LTD. automatically
Every clearance here is in the API, with alerts when new ones post.